Department of Pediatrics, Division of Critical Care, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN.
Department of Pediatrics, Division of Critical Care, St. Jude's Children's Research Hospital, Memphis, TN.
Crit Care Med. 2018 Oct;46(10):e967-e974. doi: 10.1097/CCM.0000000000003277.
Acute respiratory failure is common in pediatric hematopoietic cell transplant recipients and has a high mortality. However, respiratory prognostic markers have not been adequately evaluated for this population. Our objectives are to assess respiratory support strategies and indices of oxygenation and ventilation in pediatric allogeneic hematopoietic cell transplant patients receiving invasive mechanical ventilation and investigate how these strategies are associated with mortality.
Retrospective, multicenter investigation.
Twelve U.S. pediatric centers.
Pediatric allogeneic hematopoietic cell transplant recipients with respiratory failure.
None.
Two-hundred twenty-two subjects were identified. PICU mortality was 60.4%. Nonsurvivors had higher peak oxygenation index (38.3 [21.3-57.6] vs 15.0 [7.0-30.7]; p < 0.0001) and oxygen saturation index (24.7 [13.8-38.7] vs 10.3 [4.6-21.6]; p < 0.0001), greater days with FIO2 greater than or equal to 0.6 (2.4 [1.0-8.5] vs 0.8 [0.3-1.6]; p < 0.0001), and more days with oxygenation index greater than 18 (1.4 [0-6.0] vs 0 [0-0.3]; p < 0.0001) and oxygen saturation index greater than 11 (2.0 [0.5-8.8] vs 0 [0-1.0]; p < 0.0001). Nonsurvivors had higher maximum peak inspiratory pressures (36.0 cm H2O [32.0-41.0 cm H2O] vs 30.0 cm H2O [27.0-35.0 cm H2O]; p < 0.0001) and more days with peak inspiratory pressure greater than 31 cm H2O (1.0 d [0-4.0 d] vs 0 d [0-1.0 d]; p < 0.0001). Tidal volume per kilogram was not different between survivors and nonsurvivors.
In this cohort of pediatric hematopoietic cell transplant recipients with respiratory failure in the PICU, impaired oxygenation and use of elevated ventilator pressures were common and associated with increased mortality.
急性呼吸衰竭在儿科造血细胞移植受者中很常见,且死亡率较高。然而,尚未充分评估该人群的呼吸预后标志物。我们的目的是评估接受有创机械通气的儿科异基因造血细胞移植患者的呼吸支持策略以及氧合和通气指标,并探讨这些策略与死亡率的关系。
回顾性、多中心研究。
美国 12 家儿科中心。
患有呼吸衰竭的儿科异基因造血细胞移植受者。
无。
共确定了 222 名受试者。PICU 死亡率为 60.4%。未存活者的峰值氧合指数更高(38.3[21.3-57.6] vs 15.0[7.0-30.7];p<0.0001),氧饱和度指数更高(24.7[13.8-38.7] vs 10.3[4.6-21.6];p<0.0001),吸氧时间更长(FIO2≥0.6 的天数更多(2.4[1.0-8.5] vs 0.8[0.3-1.6];p<0.0001),氧合指数更高的天数更多(1.4[0-6.0] vs 0[0-0.3];p<0.0001)和氧饱和度指数更高的天数更多(2.0[0.5-8.8] vs 0[0-1.0];p<0.0001)。未存活者的最大吸气峰压更高(36.0 cm H2O[32.0-41.0 cm H2O] vs 30.0 cm H2O[27.0-35.0 cm H2O];p<0.0001),且更高吸气峰压的天数更多(1.0 d[0-4.0 d] vs 0 d[0-1.0 d];p<0.0001)。存活者和未存活者的潮气量/体重无差异。
在该儿科造血细胞移植受者 PICU 呼吸衰竭队列中,氧合受损和使用较高的呼吸机压力很常见,且与死亡率增加相关。